Gamify

Gamify

Early Stage

Gamify, Inc. is solving an unmet need in brain function testing.

Gamify, Inc. is solving an unmet need in brain function testing.

Overview

Raised to Date: Raised: $31,403

Total Commitments ($USD)

Platform

Netcapital

Start Date

02/14/2018

Close Date

04/14/2018

Min. Goal
$10,000
Max. Goal
$103,500
Min. Investment

$41

Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.15

Pre-Money Valuation

$2,372,137

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/28/2018

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$541

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2017

Industry

Business Services, Software, & Applications

Tech Sector

Location

Newton, Massachusetts

Who Should Be Interested:
Are your worried about concussions, especially if you have active children? Are you a doctor tired of the outdated technology used for brain function testing? If either of these sound like you, then Gamify, Inc. might be the investment you’ve been waiting for. Their products blend game design with brain science, offering a way to monitor and test brain function that’s both affordable and accessible.

The Company:
Gamify, Inc. is here to offer the first upgrade and redesign in testing brain function in nearly fifty years. They’ve created a product that’s affordable, accessible -- and fun! Users simply play their engaging and immersive role-playing games to monitor their brain function and get results. Gamify allows for frequent collection of data on cognitive skills over time, as well as real-time remote tracking of data. Gamify’s games are available on mobile phones with iOS, Android, and FireOS and online, and they can be used to monitor for injuries and for injury recovery. Their target market is athletes, parents of athletes, physicians, and athletic leagues, as well as people just generally interested in their brain health and/or enjoy gaming.

The Bottom Line:
Gamify is upping the game when it comes to brain function monitoring, and their affordable and accessible products are here to help. After all, with an anticipated two to four million concussions going to be reported this year -- and many other brain injuries going unreported -- having progressive, innovative new technology to monitor brain function and diagnose concussions is a tool all athletes and doctors need.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Gamify on Netcapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $2,372,137
Price per Share: $1.15

Follow company

Follow Gamify on Netcapital

Buy Gamify's Deal Report

Warning: according to the close date for this deal, Gamify may no longer be accepting investments.

Gamify Deal Report

Get KingsCrowd’s comprehensive report on Gamify including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Gamify is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Gamify deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge